$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

유럽의 규제과학 및 규제과학 인재양성 프로젝트
European Regulatory Science and Regulatory Science Expert Training Project 원문보기

한국임상약학회지 = Korean journal of clinical pharmacy, v.31 no.3, 2021년, pp.171 - 179  

신호철 (중앙대학교 제약산업학과) ,  박재홍 (중앙대학교 제약산업학과) ,  김지원 (중앙대학교 제약산업학과) ,  백다정 (중앙대학교 제약산업학과) ,  이윤지 (중앙대학교 약학대학) ,  정선영 (중앙대학교 제약산업학과) ,  강원구 (중앙대학교 약학대학) ,  김하형 (중앙대학교 약학대학) ,  최영욱 (중앙대학교 제약산업학과) ,  김은영 (중앙대학교 제약산업학과)

Abstract AI-Helper 아이콘AI-Helper

Background: Need for regulatory science is emerging with the development of pharmaceutical industry. It is essential to train regulatory science experts to meet the needs of technology and regulations to evaluate advanced products. Major regulatory science countries are conducting the regulatory sci...

주제어

참고문헌 (37)

  1. Hines PA, Guy RH, Humphreys AJ, Papaluca-Amati M. The European Medicines Agency's goals for regulatory science to 2025. Nat Rev Drug Discov 2019;18(6):403-4. 

  2. Sakuma I. Education and training in regulatory science for medical device development. Annu Int Conf IEEE Eng Med Biol Soc 2013:3155-8. 

  3. Hines PA, Guy RH, Brand A, Humphreys AJ, Papaluca-Amati M. Regulatory science and innovation programme for Europe (ReScIPE): A proposed model. Br J Clin Pharmacol 2020;86(12):2530-4. 

  4. Honig P, Zhang L. Regulation and innovation: Role of regulatory science in facilitating pharmaceutical innovation. Clin Pharmacol Ther 2019;105(4):778-81. 

  5. Donnelly F. Regulatory science as a means to respond to EU healthcare challenges and global market meeds. Journal of Regulatory Science. 2016;4:21-8. 

  6. Institute of Medicine. Strengthening a workforce for innovative regulatory science in therapeutics development: workshop summary. Washington (DC): National Academies Press, 2012:31-41. 

  7. Meyer RJ. The role of academic medical centers in advancing regulatory science. Clin Pharmacol Ther 2014;95(5):471-3. 

  8. Duke-NUS medical school. Center of regulatory excellence. Available from https://www.duke-nus.edu.sg/core. Accessed September 9, 2021. 

  9. European Medicines Agency. Road map to 2015. Available from https://www.ema.europa.eu/en/documents/report/road-map-2015-european-medicines-agencys-contribution-science-medicineshealth_en.pdf2010. Accessed September 9, 2021. 

  10. Gaspar R, Aksu B, Cuine A, Danhof M, Takac MJ-M, Linden HH, et al. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020. Eur J Pharm Sci 2012;47(5):979-87. 

  11. Horizon 2020. Nat Mater. 2012;11(6):477. 

  12. Laverty H, Meulien P. The innovative medicines initiative -10 years of public-private collaboration. Front Med (Lausanne) 2019;6:275. 

  13. European Medicines Agency. EMA regualtory science to 2025 strategic reflection. Available from https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ema-regulatoryscience-2025-strategic-reflection_en.pdf. Accessed September 9, 2021. 

  14. Goldman M, Wittelsberger A, De Magistris MT. The innovative medicines initiative moves translational immunology forward. Eur J Immunol 2013;43(2):298-302. 

  15. Goldman M. The innovative medicines initiative: a European response to the innovation challenge. Clin Pharmacol Ther 2012;91(3):418-25. 

  16. Goldman M, Seigneuret N, Eichler HG. The innovative medicines initiative: an engine for regulatory science. Nat Rev Drug Discov 2015;14(1):1-2. 

  17. Spindler P, Bach KF, Schmiegelow M, Bedlington N, Eichler HG. Innovation of medical products: The evolution of regulatory science, research, and education. Ther Innov Regul Sci 2016;50(1):44-8. 

  18. Innovative Medicines Initiative website. Available from https://www.imi.europa.eu/. Accessed September 9, 2021. 

  19. Dance A. Regulatory science: Researchers in the pipeline. Nature 2013;496(7445):387-9. 

  20. Innovative Medicines Initiative. Report from the IMI-EMA-FDA regulatory science summit-collaborative research through publicprivate partnership in support to advancing regulatory science. Available from https://www.imi.europa.eu/sites/default/files/uploads/documents/reference-documents/RegulatorySummit2019_report.pdf Accessed September 9, 2021. 

  21. Payton A, Janko C, Renn O, Hardman M; EMTRAIN Consortium. On-course( ® ) portal: a tool for in-service training and career development for biomedical scientists. Drug Discov Today 2013; 18(17-18):803-6. 

  22. IMI EMTRAIN website. Available from https://www.imi.europa.eu/projects-results/project-factsheets-/emtrain. Accessed September 9, 2021. 

  23. Payton A, Dallakian P, Fitton A, Payton A, Hardman M, Yuille M. Course fees and academic ranking: insights from the IMI EMTRAIN on-course ® database. Drug Discov Today 2014;19(7):830-3. 

  24. Hardman M, Brooksbank C, Johnson C, et al. LifeTrain: towards a European framework for continuing professional development in biomedical sciences. Nat Rev Drug Discov 2013;12(6):407-8. 

  25. LifeTrain website. Available from https://www.lifetrain.eu/. Accessed September 9, 2021. 

  26. Klech H, Brooksbank C, Price S, et al. European initiative towards quality standards in education and training for discovery, development and use of medicines. Eur J Pharm Sci 2012;45(5):515-20. 

  27. SafeSciMET website. Available from https://ssm.afww.unikonstanz.de/. Accessed September 9, 2021. 

  28. Eu2P website. Available from https://eu2p.org/. Accessed September 9, 2021. 

  29. Boeynaems JM, Canivet C, Chan A, et al. A European approach to clinical investigator training. Front Pharmacol 2013;4:112. 

  30. PharmaTrain website. Available from https://pharmatrain.eu/. Accesssed September 9, 2021. 

  31. Silva H, Stonier P, Buhler F, et al. Core competencies for pharmaceutical physicians and drug development scientists. Front Pharmacol 2013;4:105. 

  32. Kerpel-Fronius S, Rosenkranz B, Allen E, et al. Education and training for medicines development, regulation, and clinical research in emerging countries. Front Pharmacol 2015;6:80. 

  33. Silva H, Buhler F, Maillet B, et al. Continuing medical education and professional development in the European Union. Pharm Med 2012;26(4):223-33. 

  34. Bongiovanni S, Purdue R, Kornienko O, Bernard R. Quality in non-GXP research environment. In: Bespalov A, Michel M, Steckler T eds. Good research practice in non-clinical pharmacology and biomedicine. Handbook of Experimental Pharmacology, Cham: Springer Open, vol 257, 2020:1-17. https://doi.org/10.1007/164_2019_274. Accessed September 9, 2021 

  35. EQIPD website. Available from https://quality-preclinical-data.eu/. Accessed September 9, 2021. 

  36. Bespalov A, Bernard R, Gilis A, et al. Introduction to the EQIPD quality system. Elife. 2021;10:e63294. 

  37. Ministry of Food and Drug Safety. Regulatory science talent training project (R&D) announcement. 2021. Available from https://www.mfds.go.kr/brd/m_99/view.do?seq44172. Accessed September 9, 2021 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로